Rory B. Riggs - May 19, 2022 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role: Director
Signature: /s/ Jason Mehar, as Attorney-in-Fact for Rory B. Riggs
Stock symbol: RPRX
Transactions as of: May 19, 2022
Transactions value $: -$5,913,306
Form type: 4
Date filed: 5/23/2022, 04:55 PM
Previous filing: Apr 4, 2022
Next filing: Jun 13, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPRX	Class A Ordinary Shares	Sale	-$1.05M	-26.3K	-4.37%	$40.09	575K	May 19, 2022	Direct	F1
transaction	RPRX	Class A Ordinary Shares	Sale	-$4.86M	-124K	-21.5%	$39.28	452K	May 20, 2022	Direct	F2
holding	RPRX	Class A Ordinary Shares						85.2K	May 19, 2022	By New Ventures III LLC
holding	RPRX	Class A Ordinary Shares						15K	May 19, 2022	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.29 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $40.04 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.29 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $40.04 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.